|
Instruments, Tech Platforms, Informatics and Market Published: March 2003 155 pages; Can be printed; fully searchable PDF format; TOC hyperlinks and Internet hyperlinks
SKU: TPR3139
Price: $1,695.00 (US Dollars) PDF Single User License $1,995.00 (US Dollars) PDF Single Office License (2 to 5 users) $2,295.00 (US Dollars) PDF Global Site License
Description
This market research report is about the important market for life science tools & techs that are used for accelerating the research processes and capabilities of biopharmaceutical R&D. This key research information is valuable and offers readers a detailed overview of the size and shape of the life science tools and techs market and what the products can do to facilitate the advancement of pharmaceutical and biotech drug R&D programs.
Significant life science industry information is presented and reviewed. While pharmaceutical industry generated more than $255 billion in 2002, pharma companies are facing many important issues that could be helped by using new life science tools and technologies. A broad range of industry data is analyzed and reveals that pharma companies have seen their R&D costs dramatically increase over the last twenty years, while their product productivity has declined. In addition, many existing and profitable blockbuster drugs will reach patent expiration dates between 2005-2006. This situation will attract competition from generic or other branded drug makers. It shows that there is a clear need driving the desire for more innovation.
For buyers and sellers of life science tools and techs, this report shows that major pharma companies have increasingly become a source of significant strategic alliance opportunities for many of the companies that comprise the US biotechnology industry. Major pharma companies are motivated to become customers and partners of life science tools companies because the many "tools" companies offer technologies that enable them become more productive, reduce bottlenecks and deliver more marketable products, at less cost, and in a shorter time than in the current 10 to 15-year sequential drug development timeline.
Industrialization of pharmaceutical and biotech R&D has begun. These firms are using genomics and proteomics technologies, and other life science tools that can help these companies reach their drug product objectives. The report discusses some of the newest life science tools and tech advancements including nanobiotechnology, rolling circle amplification technology (RCAT), ICAT, RNAi, phage display, yeast 2 hybrid, PROfusion technology, surface plasmon resonance, biochips, protein arrays, separation technologies, 2D PAGE, HPLC, TOF/TOF, drug target discovery and validation tools among others.
This report has found that the life science tools & techs market size in 2002 was about $1.6 billion and is projected to more than double to about $3.5 billion by 2007, growing at a CAGR of 17.7%. While the economy is currently challenging this market, a pickup in growth is expected after 2004. Readers will learn about key business opportunities and the lessons learned from the life science tools and techs companies. This 155-page study uses 34 figures and tables to illustrate the research findings. Participating companies are mapped against multiple technologies to show where they fit in the competitive landscape. Over 27 life science tools & tech companies are profiled, and the report provides insights about the "tools & techs" that these interesting companies offer, including their strategies, funding and so on.
Table of Contents
1.Overview of the Life Science Tools & Technology Market The Competitive Marketplace Analytical Instrumentation Companies Genomics Companies Proteomics Companies Bioinformatics Software Companies BioDatabase Companies Drug Discovery Companies Emerging Tools & Technology Companies Reagent and Consumables Companies Overview of Life Science Tool & Tech Developments Gene Sequencing Systems Protein Separation Tools Mass Spectrometers (MS) Microarray and Microfluidic Analytical Technologies Emerging Technologies Informatics - IT for Life Science R&D Life Science Tool & Tech Applications for R&D Biopharmaceutical Drug Discovery R&D Diagnostic Tools Pharming Applications 2.Factors Driving Life Science Tools & Tech Developments The Opportunity to Make Multi-Billion Dollar Revenues The Pace of Pharmaceutical Mergers and Acquisitions Rapid Pace of Scientific Advancements Economics of Pharmaceutical R&D Drug Discovery R&D Creation of Post-Genomic Era R&D Databases Proteomics R&D Requires New Tools & Techs 3.Strategies for Life Science Tools & Techs for R&D Business Models and Intellectual Property Business Models Intellectual Property (IP) Commercializing Life Science Tools & Techs. Develop and Out-License Technology Produce and Sell Consumable Products for R&D Produce and Sell Equipment Platforms to R&D Customers Discover or Validate Drug Targets for Drug Discovery Strategic Goals Establish Customer Base with Large Pharmas or Biotechs Make Key Alliances or Partnerships Grow the Company to Reach Critical Mass Business Development Strategies Traditional Alliance Partnering Become a Technology Roll-up Merge with Another Biotech 4.Market Forecast Life Science Tools & Tech R&D Market Size by Segment, 2002~2007 5.Activities of Analytical Instrument Companies Affymetrix, Inc. Agilent Technologies, Inc. (Life Sciences) Cepheid Ciphergen Biosystems, Inc. 6.Activities of Bioinformatics Companies Accelrys, Inc (Subsidiary of Pharmacopeia Inc.) Celera Genomics Corporation Gene Logic, Inc. Human Genome Sciences, Inc. Incyte Corporation InforMax, Inc. (Acq. by Invitrogen) Spotfire, Inc. 7.Activities of Drug Discovery Tools Companies AVIVA Biosciences Caliper Technologies Corporation Fluidigm Corporation GeneMachines, Inc. Nanogen, Inc. 8.Activities of Emerging Technology Companies BioTrove Illumina, Inc. Nanostream PamGene Xeotron Corporation Zyomyx, Inc. 9.Activities of Reagent & Consumables Companies ACLARA BioSciences, Inc. Genicon Sciences Corporation Invitrogen Corporation Molecular Staging, Inc. Phylos, Inc. Quantum Dot Corporation 10.Future Directions of Life Science Tools for R&D Future Directions Review of Recent Trends Recent Developments in Genomics That Impact Life Science Tools Indicators of Future Trends Financing Volatility Biotechnology Conferences University Labs at Work Bioinformatics Software. Bioinformatics Databases Emerging Protein Technology Nanobiotechnology Opportunities Emerging 11.Conclusions and New Opportunities Factors for Success or Failure Highlights of Hot Development Areas of Life Science Tools Life Science Tools & Tech Opportunities Industrial Scale Proteomics The Trend Towards Individualized Medicine Summary 12.Appendix A. Tech Map of Industry Segments Target Identification Genomic Technologies Target Identification Protein Technologies Protein Chip Protein Databases Target Validation Drug Lead Screening Preclinical Development Phase I-III Clinical Development & Diagnostics 13.Appendix B. Technology Map Tables - Life Science Tools & Tech Companies 14.Appendix C. Life Science Glossary
List of Tables
Table 1. Estimated Total Life Science Tools & Techs. Market Size by Segment Revenues Table 2. Total Life Science Tools & Tech Market Segments by Market Share Percent Table 3. Drug Discovery Tools Segment by Revenues Table 4. Bioinformatics Tools Segment by Revenues Table 5. Reagents and Consumables Segment by Revenues Table 6. Emerging Technologies Segment by Revenues Table 7. Future Directions of Life Science Tools & Techs for R&D Table 8. Major Drug Discovery Tools Companies Table 9. Major Bioinformatics Tools Companies Table 10. Major Life Science Reagent & Consumables Vendors Table 11. Major Emerging Technologies Companies Table 12. Major Drug Discovery Companies
List of Figures
Figure 1. Life Science Tools & Techs Vendor Market Figure 2. The R&D Path to Make Drug Products Figure 3. Liquid Handling Systems Figure 4. Incyte's Protein Expression Analysis Software Figure 5. ScreenMate Products for HTS in Drug Lead R&D Figure 6. Rolling Circle Amplification Technology (RCAT) Figure 7. RNA Interference: Steps to Making siRNA Figure 8. The InforMax ProChart™ for Protein Visualization Figure 9. Computer Model using PhysioLab Technology Figure 10. Big Pharma and Big Biotech Drug R&D Timeline Figure 11. Using Parallel Processes to Increase Drug Discovery Productivity Figure 12. Estimated Total Life Science Tools & Techs Market Size by Revenues Figure 13. Estimated Total Life Science Tools & Tech Market Size by Segment Revenues, 2002-2007 Figure 14. Comparison of Estimated Total Life Science Tools & Tech Market Size by Segment Revenues, 2002-2007 Figure 15. Comparison of Segment Market Shares for the Life Science Tools & Tech Market, 2002 and 2007 Figure 16. Drug Discovery Tools Segment by Revenues Figure 17. Bioinformatics Tools Segment by Revenues Figure 18. Reagents and Consumable Life Science Tools Segment by Revenues Figure 19. Emerging Technologies Segment by Revenues Figure 20. Spotfire DecisionSite Figure 21. Accelrys GCG Wisconsin Package – SeqLab Figure 22. The Incyte/ Oxford Glycoscience Proteome Analysis Process Figure 23. Life Science Tools & Techs Opportunity Map
|
||